Pfizer: One of the world's premier biopharmaceutical companies
WebPfizer prioritizes the health and well-being of people and the planet to deliver breakthroughs around the world in a responsible way. Learn more in Pfizer’s 2023 Impact Report Behind the Science Feature
Our Products: Holding the Promise of a Breakthrough | Pfizer
WebIn this section find an overview of our Pfizer Products and search for information on our most popular Pfizer products. Our products are the results of 1500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription.
Pfizer - Wikipedia
WebPfizer Inc. (/ ˈ f aɪ z ər / FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer (1824–1906) and his cousin Charles F. Erhart (1821–1891).
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WebDec 11, 2020 · COMIRNATY is the first COVID-19 vaccine to be granted approval by the FDA. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210823005499/en/ The vaccine has been available in the U.S. under Emergency Use Authorization (EUA) since December 11, 2020 (as the Pfizer-BioNTech COVID-19 Vaccine).
Coronavirus COVID-19: Vaccine, Drug and Treatment Updates - Pfizer
WebPfizer Inc. and BioNTech SE announced today they have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the effect of a booster on immunity against COVID-19 caused by the circulating and potential newly emerging SARS-CoV-2 variants.
FDA Approves First COVID-19 Vaccine | FDA
WebAugust 23, 2021. Español. Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be...
FDA Authorizes Booster Dose of Pfizer-BioNTech COVID-19 …
WebSep 22, 2021 · 888-INFO-FDA. FDA amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to allow for the use of a single booster dose, to be administered at least six months after ...
Pfizer Coronavirus Resources: Covid-19 Updates, News, Information | Pfizer
WebCoronavirus Resources: COVID-19 Information and Our Scientific Efforts. Our scientific efforts played an important role during a global health crisis. Learn more about SARS-CoV-2, the coronavirus that causes COVID-19 disease, and …
Pfizer and BioNTech Announce Omicron-Adapted COVID-19 …
WebSaturday, June 25, 2022 - 10:00am. View pdf copy Copy to clipboard Open in tab. Omicron-adapted monovalent candidate given as a fourth booster dose elicited a 13.5 and 19.6-fold increase in neutralizing geometric titers against Omicron BA.1 at 30 µg and 60 µg dose levels; bivalent vaccine candidate exhibited a 9.1 and 10.9-fold increase ...
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High …
WebSep 22, 2021 · NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10,000 individuals 16 …
Skip to content